October 3, 2019

International Patent Application No. PCT/EP2019/057386

On 3rdOctober 2019, PCT application titled “Means and methods for glycoprofiling of aprotein” (applicant Glycanostics, inventors Tomas Bertok and Jan Tkac) waspublished under publication number WO 2019/185515. This patent applicationcovers the main principles and company´s IP used during the diagnostic assaydevelopment.

Patent abstract: Thepresent invention provides magnetic carriers, anti-glycoprotein antibodies, theantigen binding portions thereof, one or more lectins, compositions, kits,methods and uses based thereon including uses in methods for glycoprofiling ofglycoproteins using lectins, e.g., in diagnostics of cancer. The magneticcarriers, anti-glycoprotein antibodies, the antigen binding portions thereof,one or more lectins, compositions, kits, methods and uses based thereon areapplicable to any glycoprotein.

Other News

October 18, 2019

A highly-prestigious award for a Glycanostics co-founder

ESET launched a prestigious ESET Science Award for exceptional scientists

August 31, 2019

Glycanostics succesfully finished Horizon 2020 SME Instrument 1 Grant

Glycanostics successfully finished the first phase of SME Instrument

December 10, 2018

Glycanostics Wins Horizon 2020 Grant

After receiving the prestigious “Seal of Excellence” on October 23, the next submission to the Horizon 2020 Programme, won a € 50 000 grant.

October 27, 2018

Glycanostics Receives the Prestigious Horizon 2020 “Seal of Excellence”

This project received the highest scores for its proposal in the extremely competitive evaluation process.

October 24, 2018

Glycanostics Wins TOP-6 Best Startups in Central Europe

Glycanostics was chosen as a finalist in the Grand Finale with five other remarkable startups.

August 14, 2018

Glycanostics Applies for Innovation-Securing Patent

The application covering Glycanostics' diagnostic method is currently filed in two patent offices in Europe and Luxemburg.

July 27, 2018

Glycanostics wins the European Research Council Grant

Glycanoctics innovations are again supported and highly ranked by leading industry experts. This time the company won the European Research Council (ERC) Proof of Concept Grant.

June 14, 2018

Glycanostics Takes 3rd Place in Vodafone’s Idea of The Year Competition

The competition's objectives are to actively support innovative projects with high market potential

May 1, 2018

Glycanostics PCa DX kit showed 95+% accuracy on the pre-clinical validation

In April 2018 the technology validation was successfully completed indicating a great potential of Glycanostics innovative products for prostate cancer (PCa) diagnostics.

November 30, 2017

Jan Tkac and Tomas Bertok – Scientists of the year award winners - establish Glycanostics to bring their revolutionary innovation to cancer diagnostics market

Glycanostics is an innovative start-up company established in 2017 to bring its revolutionary cancer diagnostics products to the US and EU markets.